A |
2025-01-23 |
|
GLOBUS MEDICAL INC |
4 |
A-Award |
--D |
15000.0000 |
15000.0000 |
1 |
0001237831 |
Stock Option (Right to Buy Class A Common Stock) |
A |
2024-11-21 |
|
CVS HEALTH Corp |
4 |
A-Award |
--D |
2200.0000 |
2200.0000 |
1 |
0000064803 |
Common Stock |
D |
2024-07-11 |
|
GLOBUS MEDICAL INC |
4 |
S-Sale |
--D |
1000.0000 |
16419.0000 |
1 |
0001237831 |
Class A Common Stock |
A |
2024-05-29 |
|
ARVINAS, INC. |
4 |
A-Award |
--D |
5899.0000 |
10020.0000 |
1 |
0001655759 |
Common Stock |
A |
2024-05-29 |
|
ARVINAS, INC. |
4 |
A-Award |
--D |
9070.0000 |
9070.0000 |
2 |
0001655759 |
Stock Option (right to buy) |
A |
2024-05-22 |
|
NEUROCRINE BIOSCIENCES INC |
4 |
A-Award |
--D |
1435.0000 |
1435.0000 |
1 |
0000914475 |
Restricted Stock Unit |
A |
2024-05-22 |
|
NEUROCRINE BIOSCIENCES INC |
4 |
A-Award |
--D |
2982.0000 |
2982.0000 |
2 |
0000914475 |
Non-Qualified Stock Option |
A |
2024-05-17 |
|
NEUROCRINE BIOSCIENCES INC |
4 |
M-Exempt |
--D |
2100.0000 |
2100.0000 |
1 |
0000914475 |
Common Stock |
D |
2024-05-17 |
|
NEUROCRINE BIOSCIENCES INC |
4 |
S-Sale |
--D |
1106.0000 |
994.0000 |
2 |
0000914475 |
Common Stock |
D |
2024-05-17 |
|
NEUROCRINE BIOSCIENCES INC |
4 |
M-Exempt |
--D |
2100.0000 |
0.0000 |
3 |
0000914475 |
Restricted Stock Unit |
D |
2024-03-15 |
|
GLOBUS MEDICAL INC |
4 |
S-Sale |
--D |
10590.0000 |
17419.0000 |
1 |
0001237831 |
Class A Common Stock |
A |
2024-02-27 |
|
NEUROCRINE BIOSCIENCES INC |
4 |
M-Exempt |
--D |
8000.0000 |
8000.0000 |
1 |
0000914475 |
Common Stock |
D |
2024-02-27 |
|
NEUROCRINE BIOSCIENCES INC |
4 |
S-Sale |
--D |
8000.0000 |
0.0000 |
2 |
0000914475 |
Common Stock |
D |
2024-02-27 |
|
NEUROCRINE BIOSCIENCES INC |
4 |
M-Exempt |
--D |
8000.0000 |
1724.0000 |
3 |
0000914475 |
Non-Qualified Stock Option |
A |
2024-02-14 |
|
ModivCare Inc |
4 |
A-Award |
--D |
2658.0000 |
18830.0000 |
1 |
0001220754 |
Common Stock |
A |
2024-01-26 |
|
GLOBUS MEDICAL INC |
4 |
A-Award |
--D |
15000.0000 |
15000.0000 |
1 |
0001237831 |
Stock Option (Right to Buy Class A Common Stock) |
D |
2023-09-01 |
|
NUVASIVE INC |
4 |
D-Return |
--D |
3095.0000 |
0.0000 |
1 |
0001142596 |
Common Stock, par value $0.001 per share |
D |
2023-09-01 |
|
NUVASIVE INC |
4 |
D-Return |
--D |
5960.0000 |
0.0000 |
2 |
0001142596 |
Restricted Stock |
D |
2023-09-01 |
|
NUVASIVE INC |
4 |
D-Return |
--D |
3725.0000 |
0.0000 |
3 |
0001142596 |
Restricted Stock |
D |
2023-09-01 |
|
NUVASIVE INC |
4 |
D-Return |
--D |
2501.0000 |
0.0000 |
4 |
0001142596 |
Restricted Stock |
D |
2023-09-01 |
|
NUVASIVE INC |
4 |
D-Return |
--D |
2822.0000 |
0.0000 |
5 |
0001142596 |
Restricted Stock |
D |
2023-09-01 |
|
NUVASIVE INC |
4 |
D-Return |
--D |
2130.0000 |
0.0000 |
6 |
0001142596 |
Restricted Stock |
D |
2023-09-01 |
|
NUVASIVE INC |
4 |
D-Return |
--D |
3230.0000 |
0.0000 |
7 |
0001142596 |
Restricted Stock |
D |
2023-09-01 |
|
NUVASIVE INC |
4 |
D-Return |
--D |
2577.0000 |
0.0000 |
8 |
0001142596 |
Restricted Stock |
D |
2023-09-01 |
|
NUVASIVE INC |
4 |
D-Return |
--D |
2702.0000 |
0.0000 |
9 |
0001142596 |
Restricted Stock |
D |
2023-09-01 |
|
NUVASIVE INC |
4 |
D-Return |
--D |
3788.0000 |
0.0000 |
10 |
0001142596 |
Restricted Stock |
D |
2023-09-01 |
|
NUVASIVE INC |
4 |
D-Return |
--D |
4816.0000 |
0.0000 |
11 |
0001142596 |
Restricted Stock |
A |
2023-09-01 |
|
GLOBUS MEDICAL INC |
4 |
A-Award |
--D |
2321.0000 |
2321.0000 |
1 |
0001237831 |
Class A Common Stock |
A |
2023-09-01 |
|
GLOBUS MEDICAL INC |
4 |
A-Award |
--D |
25688.0000 |
28009.0000 |
2 |
0001237831 |
Class A Common Stock |
A |
2023-09-01 |
|
GLOBUS MEDICAL INC |
4 |
A-Award |
--D |
15000.0000 |
15000.0000 |
3 |
0001237831 |
Stock Option (Right to Buy Class A Common Stock) |
A |
2023-06-15 |
|
ARVINAS, INC. |
4 |
A-Award |
--D |
4121.0000 |
4121.0000 |
1 |
0001655759 |
Common Stock |
A |
2023-06-15 |
|
ARVINAS, INC. |
4 |
A-Award |
--D |
12787.0000 |
12787.0000 |
2 |
0001655759 |
Stock Option (right to buy) |
A |
2023-06-09 |
|
NUVASIVE INC |
4 |
A-Award |
--D |
4816.0000 |
4816.0000 |
1 |
0001142596 |
RSUs |
A |
2023-05-17 |
|
NEUROCRINE BIOSCIENCES INC |
4 |
A-Award |
--D |
4290.0000 |
4290.0000 |
1 |
0000914475 |
Non-Qualified Stock Option |
A |
2023-05-17 |
|
NEUROCRINE BIOSCIENCES INC |
4 |
A-Award |
--D |
2100.0000 |
2100.0000 |
2 |
0000914475 |
Restricted Stock Unit |
A |
2023-02-16 |
|
ModivCare Inc |
4 |
A-Award |
--D |
1314.0000 |
16172.0000 |
1 |
0001220754 |
Common Stock |
A |
2022-06-16 |
|
ARVINAS, INC. |
4 |
A-Award |
--D |
10192.0000 |
10192.0000 |
1 |
0001655759 |
Stock Option (right to buy) |
A |
2022-06-01 |
|
NUVASIVE INC |
4 |
M-Exempt |
--D |
1547.0000 |
3095.0000 |
1 |
0001142596 |
Common Stock |
D |
2022-06-01 |
|
NUVASIVE INC |
4 |
M-Exempt |
--D |
1547.0000 |
0.0000 |
2 |
0001142596 |
RSUs |
A |
2022-05-18 |
|
NEUROCRINE BIOSCIENCES INC |
4 |
A-Award |
--D |
9724.0000 |
9724.0000 |
1 |
0000914475 |
Non-Qualified Stock Option |
A |
2022-05-11 |
|
NUVASIVE INC |
4 |
A-Award |
--D |
3788.0000 |
3788.0000 |
1 |
0001142596 |
RSUs |
A |
2022-03-31 |
|
CENTENE CORP |
4 |
A-Award |
--D |
381.0050 |
1481.0050 |
1 |
0001071739 |
Common Stock |
A |
2022-02-07 |
|
CENTENE CORP |
4 |
A-Award |
--D |
1100.0000 |
1100.0000 |
1 |
0001071739 |
Common Stock |
A |
2022-02-07 |
|
CENTENE CORP |
4 |
A-Award |
--D |
10000.0000 |
10000.0000 |
2 |
0001071739 |
Common Stock Option (right to buy) |
A |
2022-02-07 |
|
ModivCare Inc |
4 |
A-Award |
--D |
1223.0000 |
14858.0000 |
1 |
0001220754 |
Common Stock |
D |
2022-01-04 |
|
MAGELLAN HEALTH INC |
4 |
D-Return |
--D |
5698.0000 |
0.0000 |
1 |
0000019411 |
Ordinary Common Stock, $0.01 par value |
A |
2021-08-13 |
|
MAGELLAN HEALTH INC |
4 |
A-Award |
--D |
789.0000 |
5698.0000 |
1 |
0000019411 |
Ordinary Common Stock, $0.01 par value |
A |
2021-06-08 |
|
ARVINAS, INC. |
4 |
A-Award |
--D |
7511.0000 |
7511.0000 |
1 |
0001655759 |
Stock Option (right to buy) |
A |
2021-06-01 |
|
NUVASIVE INC |
4 |
M-Exempt |
--D |
1548.0000 |
1548.0000 |
1 |
0001142596 |
Common Stock |
D |
2021-06-01 |
|
NUVASIVE INC |
4 |
M-Exempt |
--D |
1548.0000 |
1547.0000 |
2 |
0001142596 |
RSUs |
A |
2021-05-19 |
|
NEUROCRINE BIOSCIENCES INC |
4 |
A-Award |
--D |
8833.0000 |
8833.0000 |
1 |
0000914475 |
Non-Qualified Stock Option |
A |
2021-05-18 |
|
NUVASIVE INC |
4 |
A-Award |
--D |
2702.0000 |
2702.0000 |
1 |
0001142596 |
RSUs |
A |
2021-02-10 |
|
ModivCare Inc |
4 |
A-Award |
--D |
725.0000 |
13635.0000 |
1 |
0001220754 |
Common Stock |
A |
2020-06-17 |
|
MAGELLAN HEALTH INC |
4 |
A-Award |
--D |
2122.0000 |
4909.0000 |
1 |
0000019411 |
Ordinary Common Stock, $0.01 par value |
A |
2020-06-03 |
|
ARVINAS, INC. |
4 |
A-Award |
--D |
12000.0000 |
12000.0000 |
1 |
0001655759 |
Stock Option (right to buy) |
A |
2020-05-28 |
|
NUVASIVE INC |
4 |
A-Award |
--D |
3095.0000 |
3095.0000 |
1 |
0001142596 |
RSUs |
A |
2020-05-19 |
|
NEUROCRINE BIOSCIENCES INC |
4 |
A-Award |
--D |
6018.0000 |
6018.0000 |
1 |
0000914475 |
Non-Qualified Stock Option |
A |
2020-02-13 |
|
PROVIDENCE SERVICE CORP |
4 |
A-Award |
--D |
1952.0000 |
12910.0000 |
1 |
0001220754 |
Common Stock |
A |
2019-09-10 |
|
NEUROCRINE BIOSCIENCES INC |
4 |
A-Award |
--D |
15000.0000 |
15000.0000 |
1 |
0000914475 |
Non-Qualified Stock Option |
A |
2019-08-05 |
|
ENDOLOGIX INC /DE/ |
4 |
A-Award |
--D |
13494.0000 |
29932.0000 |
1 |
0001013606 |
Common Stock |
A |
2019-08-05 |
|
ENDOLOGIX INC /DE/ |
4 |
A-Award |
--D |
9023.0000 |
9023.0000 |
2 |
0001013606 |
Option to Purchase |
A |
2019-07-24 |
|
ARVINAS, INC. |
4 |
A-Award |
--D |
25846.0000 |
25846.0000 |
1 |
0001655759 |
Stock Option (right to buy) |
A |
2019-06-21 |
|
MAGELLAN HEALTH INC |
4 |
A-Award |
--D |
2251.0000 |
2787.0000 |
1 |
0000019411 |
Ordinary Common Stock, $0.01 par value |
A |
2019-05-09 |
|
NUVASIVE INC |
4 |
A-Award |
--D |
2577.0000 |
2577.0000 |
1 |
0001142596 |
RSUs |
A |
2019-05-01 |
|
MAGELLAN HEALTH INC |
4 |
A-Award |
--D |
536.0000 |
536.0000 |
1 |
0000019411 |
Ordinary Common Stock, $0.01 par value |
A |
2019-02-14 |
|
PROVIDENCE SERVICE CORP |
4 |
A-Award |
--D |
1857.0000 |
10958.0000 |
1 |
0001220754 |
Common Stock |
A |
2018-12-30 |
|
ENDOLOGIX INC /DE/ |
4 |
A-Award |
--D |
120887.0000 |
164378.0000 |
1 |
0001013606 |
Common Stock |
A |
2018-05-03 |
|
NUVASIVE INC |
4 |
A-Award |
--D |
3230.0000 |
3230.0000 |
1 |
0001142596 |
RSUs |
A |
2018-02-16 |
|
PROVIDENCE SERVICE CORP |
4 |
A-Award |
--D |
2017.0000 |
9101.0000 |
1 |
0001220754 |
Common Stock |
A |
2017-05-31 |
|
ENDOLOGIX INC /DE/ |
4 |
A-Award |
--D |
22822.0000 |
43491.0000 |
1 |
0001013606 |
Common Stock |
A |
2017-05-18 |
|
NUVASIVE INC |
4 |
A-Award |
--D |
2130.0000 |
2130.0000 |
1 |
0001142596 |
RSUs |
A |
2017-03-03 |
|
PROVIDENCE SERVICE CORP |
4 |
A-Award |
--D |
3097.0000 |
7084.0000 |
1 |
0001220754 |
Common Stock |
D |
2016-10-21 |
|
Press Ganey Holdings, Inc. |
4 |
D-Return |
--D |
28770.0000 |
0.0000 |
1 |
0001633142 |
Common Stock |
A |
2016-06-21 |
|
Press Ganey Holdings, Inc. |
4 |
A-Award |
--D |
3402.0000 |
28770.0000 |
1 |
0001633142 |
Common Stock |
A |
2016-06-02 |
|
ENDOLOGIX INC /DE/ |
4 |
A-Award |
--D |
7657.0000 |
20669.0000 |
1 |
0001013606 |
Common Stock |
A |
2016-05-19 |
|
NUVASIVE INC |
4 |
A-Award |
--D |
2822.0000 |
2822.0000 |
1 |
0001142596 |
RSUs |
A |
2016-03-14 |
|
PROVIDENCE SERVICE CORP |
4 |
A-Award |
--D |
3360.0000 |
3987.0000 |
1 |
0001220754 |
Common Stock |
A |
2015-11-04 |
|
PROVIDENCE SERVICE CORP |
4 |
A-Award |
--D |
627.0000 |
627.0000 |
1 |
0001220754 |
Common Stock |
A |
2015-06-12 |
|
NUVASIVE INC |
4 |
A-Award |
--D |
2501.0000 |
0.0000 |
1 |
0001142596 |
Common Stock |
A |
2015-05-21 |
|
Press Ganey Holdings, Inc. |
4 |
A-Award |
--D |
5000.0000 |
25368.0000 |
1 |
0001633142 |
Common Stock |